
News|Articles|April 1, 2002
Zometa (Zoledronic acid for injection), Novartis
New indication: Bisphosphonate cleared for multiple myeloma, metastases of solid tumors
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
A conversation about using GLP-1s to manage antipsychotic weight gain, with Mahavir Agarwal, M.D., Ph.D.
4
Ashley Holzworth-Nash, Pharm.D., Evernorth
5






















